Correlation Between Amylyx Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Amylyx Pharmaceuticals and Cullinan Oncology
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Amylyx and Cullinan is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.89 times more return on investment than Cullinan Oncology. However, Amylyx Pharmaceuticals is 1.89 times more volatile than Cullinan Oncology LLC. It trades about 0.13 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.25 per unit of risk. If you would invest 408.00 in Amylyx Pharmaceuticals on August 17, 2024 and sell it today you would earn a total of 68.00 from holding Amylyx Pharmaceuticals or generate 16.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Amylyx Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
Timeline |
Amylyx Pharmaceuticals |
Cullinan Oncology LLC |
Amylyx Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amylyx Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Amylyx Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Cullinan Oncology vs. Immix Biopharma | Cullinan Oncology vs. ZyVersa Therapeutics | Cullinan Oncology vs. Hepion Pharmaceuticals | Cullinan Oncology vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |